menu toggle

Report: Building successful cell and gene therapy supply chains

By AmerisourceBergen

This report from Scrip Pharma Intelligence summarizes the takeaways from a recent roundtable with a panel of experts representing early stage biotech, pharmaceutical, supply chain management and logistics companies:

  • Orchestrating cell and gene therapies requires bespoke solutions in terms of storage, transportation, timelines, temperature control, and servicer flexibility
  • In these incredibly complex supply chains, forming and orchestrating partnerships is a necessity
  • In order for logistics vendors to form partnerships with cell and gene therapy manufacturers it is important to understand each company's unique requirements
  • Scalability of logistics solutions is also an important consideration